antisense oligonucleotides mechanism of action

0:13:09

Antisense oligonucleotides explained | ASO mechanism | @BiologyLectures

0:02:13

Fixing Genes with Antisense Oligonucleotides (ASOs)

0:01:05

How Does It Work? | Antisense Oligonucleotide Therapy

1:16:45

Antisense Oligonucleotides- Mechanisms of Action and Rational Design

0:01:52

Antisense oligonucleotides (ASOs)

0:03:52

Treating Disease at the RNA Level with Oligonucleotides

0:01:24

How Does It Work? | Oligonucleotide Therapies

0:02:31

Antisense Oligonucleotides | ASOs | Antisense Oligonucleotide Therapy | Antisense Therapy

0:11:24

In the Pipeline: Reducing Inflammation - Antisense Therapeutics

0:09:25

What are oligonucleotide therapeutics, and how do they work?

0:01:42

Oligonucleotide-based therapeutics

0:25:30

HOT TOPICS | Gene Expression | Modulating with Oligonucleotide-based Therapies

0:01:28

Prosensa's Video Animation on Exon Skipping

1:07:07

Submerge in the Oligonucleotide Emerge: Best Practices for Developing These Complex Biologics

0:25:14

Regulatory Applications of a Nonclinical Database for Oligonucleotide Therapeutics at U.S. FDA

0:25:45

A Visual Exploration of Antisense Oligonucleotide Therapies in ALS

0:02:31

Antisense Oligonucleotides: An Emerging Area in Drug Development

0:23:35

Antisense oligonucleotide therapy

0:19:30

Antisense oligonucleotides and CRISPR-based technologies - Petra Sušjan, PhD

0:55:19

Webinar: Antisense Therapeutics Phase II Trial Final Data Results (June 2020)

0:49:43

Track 4: Making Sense of Antisense and Other Oligonucleotide Therapies

2:03:11

Education Workshop (2021 Annual Meeting)

1:03:42

David Corey: Guidelines for Experiments using Antisense Oligonucleotides and Double-Stranded RNAs

1:04:31

Antisense Oligonucleotide based Therapies for Inherited Retinal Diseases From Mutation to Clinical